NeuroOne Medical Technologies Corporation (NMTC) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for NeuroOne Medical Technologies Corporation in 2026. The next earnings report is expected on December 16, 2026.
Next earnings date
16 Dec 2026
In 118 days
EPS estimate
-0.22
Revenue estimate
2.8M
Past earnings
No dividend history available.
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation (NMTC) is scheduled to report earnings on December 16, 2026.
NeuroOne Medical Technologies Corporation (NMTC) last reported earnings on August 13, 2026.
NeuroOne Medical Technologies Corporation (NMTC) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.